Seminoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
*In case of seminoma, the healthcare team creates an individualized treatment plan. It is generally based on the patient's needs and may include a combination of different treatments. The factors which help in deciding the treatment plan for seminoma include:<ref name="treatmentsoftesticularcancer">Treatments for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/?region=on. Accessed on March 1, 2016</ref> | *In case of seminoma, the healthcare team creates an individualized treatment plan. It is generally based on the patient's needs and may include a combination of different treatments. The factors which help in deciding the treatment plan for seminoma include:<ref name="treatmentsoftesticularcancer">Treatments for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/?region=on. Accessed on March 1, 2016</ref><ref name="Cullen2012">{{cite journal|last1=Cullen|first1=M.|title=Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours|journal=Annals of Oncology|volume=23|issue=suppl 10|year=2012|pages=x342–x348|issn=0923-7534|doi=10.1093/annonc/mds306}}</ref> | ||
:*Stage of seminoma | :*Stage of seminoma | ||
:*Risk of recurrence | :*Risk of recurrence |
Revision as of 17:19, 2 May 2019
Seminoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Seminoma medical therapy On the Web |
American Roentgen Ray Society Images of Seminoma medical therapy |
Risk calculators and risk factors for Seminoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
The optimal therapy for seminoma depends on the stage at diagnosis.
Medical Therapy
- In case of seminoma, the healthcare team creates an individualized treatment plan. It is generally based on the patient's needs and may include a combination of different treatments. The factors which help in deciding the treatment plan for seminoma include:[1][2]
- Stage of seminoma
- Risk of recurrence
- Fertility
- Preferences of the individual
- The various treatment options depending on the stage and recurrence risk of seminoma are discussed below:[3][4][5][6][7]
Treatment of Seminoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stage I | Stage II | Stage III | Recurrent | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemotherapy
- Chemotherapy is a common treatment for all stages of seminoma. It is usually given after an orchiectomy. A combination of chemotherapy drugs is usually given.[8]
- BEP is the main chemotherapy combination used for seminoma. It includes bleomycin, etoposide, and cisplatin.
- Sometimes, physicians just give etoposide and cisplatin (called EP). EP is given when bleomycin affects the lungs (called pulmonary toxicity), or there is a high risk that it will cause lung damage.
- High-dose chemotherapy and stem cell transplant may be used for recurrent testicular cancer, if the standard-dose chemotherapy doesn’t work and the cancer comes back.
- High doses of carboplatin and etoposide are given. After high-dose chemotherapy, a stem cell transplant is done to replace the stem cells that are damaged or destroyed by high-dose chemotherapy. The stem cell transplant is an autologous peripheral blood stem cell transplant.[8]
Radiotherapy
- Seminoma is a radiosensitive tumor (vs. nonseminomatous germ cell tumors)
- Radiation therapy may be used to treat stage I or II seminomas after orchiectomy.[8]
- It is given as external beam radiation therapy.
- Radiation is directed at the lymph nodes in the abdomen and pelvis.[8]
Active Surveillance
- Active surveillance is the preferred treatment for stage I seminoma after a radical inguinal orchiectomy.[8]
- During active surveillance, the healthcare team watches for any signs and symptoms of recurrence. Treatment is given only if seminoma recurs.[8]
- There are no standard active surveillance schedules for seminoma. Active surveillance may last for 5-10 years. You may have follow-up visits every 2-6 months for the first 3 years.[9]
- Tests that are often done during a follow-up visit include:[9]
- Physical exam
- Blood tests to check serum tumor marker levels
- Chest x-ray
- CT scan of the abdomen
References
- ↑ Treatments for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/?region=on. Accessed on March 1, 2016
- ↑ Cullen, M. (2012). "Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours". Annals of Oncology. 23 (suppl 10): x342–x348. doi:10.1093/annonc/mds306. ISSN 0923-7534.
- ↑ Treatment for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/?region=on. Accessed on March 1, 2016
- ↑ Treatments for stage I seminoma. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/seminoma/stage-i/?region=on. Accessed on March 1, 2016
- ↑ Treatments for stage II seminoma. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/seminoma/stage-ii/?region=on. Accessed on March 1, 2016
- ↑ Treatments for stage III seminoma. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/seminoma/stage-iii/?region=on. Accessed on March 1, 2016
- ↑ Treatments for recurrent seminoma. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/seminoma/recurrent/?region=on. Accessed on March 1, 2016
- ↑ 8.0 8.1 8.2 8.3 8.4 8.5 Treatments for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/?region=on. Accessed on March 2, 2016
- ↑ 9.0 9.1 Active surveillance for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/active-surveillance/?region=on. Accessed on March 2, 2016